| Journal of General Virology |
| First posted online 10 August 2000 | ARTICLE ABSTRACT |
| Rec 19 July 2000; Acc 7 August 2000 | DOI: 10.1099/vir.0.17291-0 |
Linda A. Terry, James P. Stewart, Anthony A. Nash and John K. Fazakerley
Laboratory for Clinical and Molecular
Virology, University of Edinburgh, Summerhall, Edinburgh EH9 1QH, UK
Current address: Veterinary Laboratory Agency, Weybridge, UK.
Murine gammaherpesvirus-68 (MHV-68) was originally
isolated from a bank vole by passage through mouse brain. Given its
ability to replicate in mouse brain and its subsequent reisolation from
trigeminal ganglia, it was originally considered to be an
alphaherpesvirus. Molecular studies have now firmly established MHV-68 to
be a gammaherpesvirus. Other gammaherpesviruses have been suggested to
cause and in some cases shown to cause neurological disease. Given the
isolation history of MHV-68, we have studied the ability of this virus to
gain access to, to replicate in and to persist in the mouse CNS. Following
intranasal inoculation the virus was not generally neuroinvasive. However,
in mice with a deletion of the type-I interferon receptor gene, peripheral
virus titres are higher and perivascular CNS infection was observed. There
was no evidence of virus spread via olfactory routes. Direct intracerebral
inoculation of virus was fatal with widespread infection and destruction
predominantly of meningeal and ependymal cells. Hippocampal pyramidal
neurons, oligodendrocytes, Bergmann glia cells in the cerebellar cortex
and neural progenitor cells in the rostral migratory stream were also
infected. A similar infection was observed in younger mice. CNS infection
following virus reactivation was investigated by implantation of infected
glial cells. Implantation into a brain ventricle led to widespread fatal
infection, principally involving ependymal and meningeal cells.
Implantation into the striatum resulted in a predominantly neuronal
infection. Implantation of cells into mice transiently treated with the
antiviral thionucleoside analogue 2´-deoxy-5-ethyl-
-4´-thiouridine resulted in survival with detection of
virus-infected cells in the brain 1 year later.
© 2000 SGM
This article is now available in the November 2000 print issue of JGV (vol. 81, 26352643). The complete issue of the journal may be seen in electronic form on JGV Online.